Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec 9;131(48):17528-9.
doi: 10.1021/ja9054542.

Evidence of diketopiperazine and oxazolone structures for HA b2+ ion

Affiliations

Evidence of diketopiperazine and oxazolone structures for HA b2+ ion

Brittany R Perkins et al. J Am Chem Soc. .

Abstract

Peptide fragmentation can lead to an oxazolone or diketopiperazine b(2)(+) ion structure. IRMPD spectroscopy combined with computational modeling and gas-phase H/D exchange was used to study the structure of the b(2)(+) ion from protonated HAAAA. The experimental spectrum of the b(2)(+) ion matches both the experimental spectrum for the protonated cyclic dipeptide HA (a commercial diketopiperazine) and the theoretical spectrum for a diketopiperazine protonated at the imidazole pi nitrogen. A characteristic band at 1875 cm(-1) and increased abundance of the peaks at 1619 and 1683 cm(-1) indicate a second population corresponding to an oxazolone species. H/D exchange also shows a mixture of two populations consistent with a mixture of b(2)(+) ion diketopiperazine and oxazolone structures.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
IRMPD spectra (fragmentation efficiency vs. wavenumber) of a) the b2+ ion produced by CID fragmentation of protonated HA4 and b) protonated cyclic HA dipeptide. Calculated spectra for selected c) diketopiperazine and d) oxazolone structures. Arrows indicate protonation site.
FIGURE 2
FIGURE 2
H/D exchange of a) protonated cHA and b) HA b2+ ion with increasing exchange time.

Similar articles

Cited by

References

    1. Yalcin T, et al. J. Am. Soc. Mass Spectrom. 1995;6:1165–1174. - PubMed
    2. Nold MJ, et al. Int. J. Mass Spectrom. Ion Proc. 1997;164:137–153.
    3. Vaisar T, Urban J. European Mass Spectrom. 1998;4:359–364.
    4. Haselmann KF, et al. Rapid Commun. Mass Spectrom. 2000;14:2242–2246. - PubMed
    5. Paizs B, et al. Int. J. Mass Spectrom. 2002;219:203–232.
    6. Riba-Garcia I, et al. J. Am. Soc. Mass Spectrom. 2008;19:609–613. - PubMed
    1. Savitski MM, Hith M, Fung YME, Adams CM, Zubarev RA. J. Am. Soc. Mass Spectrom. 2008;19:1755–1763. - PubMed
    1. Eckart K, et al. J. Am. Soc. Mass Spectrom. 1998;9:1002–1011.
    2. Harrison AG, et al. J. Am. Soc. Mass Spectrom. 2000;11:427–436. - PubMed
    3. Paizs B, Suhai S. Rapid Commun. Mass Spectrom. 2002;16:375–389. - PubMed
    4. Paizs B, Suhai S. J. Am. Soc. Mass Spectrom. 2003;14:1454–1469. - PubMed
    5. El Aribi H, et al. J. Am. Chem. Soc. 2003;125:9229–9236. - PubMed
    6. El Aribi H, et al. J. Phys. Chem. B. 2004;108:18743–18749.
    7. Bythell BJ, et al. J. Am. Soc. Mass Spectrom. 2007;18:1291–1303. - PubMed
    1. Farrugia JM, O'Hair RAJ, Reid GE. Int. J. Mass Spectrom. 2001;210:71–87.
    1. Farrugia JM, Taverner T, O'Hair RAJ. Int. J. Mass Spectrom. 2001;209:99–112.

Publication types